English | Spanish
ecancer
Supporting oncology professionals through education
Login Register

The content on this site is intended for healthcare professionals only

  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

News

  • Latest news
  • Sign up for news alerts
  • Submit your news

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Journal information

  • Journal home
  • Charges
  • Editorial board
  • Founding editors
  • Editor-in-chief
  • Contact us

Author information

  • Submit article
  • Author guidelines
  • Editorial policies
  • Copyright information
  • Why publish with us

Reviewer information

  • Reviewer guidelines

Memberships

Open Access Scholarly Publishers Association Crossref Healthcare Information For All Commitee On Publication Ethics

Videos

  • Recent videos
  • Sign up

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Conferences

  • Latest conferences
  • Sign up for latest coverage
  • Submit your event

About ecancer

  • About ecancer
  • Our founders
  • Funding statement
  • Contact us
  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology
+ -
Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

ecancer and the City Cancer Challenge have formed an educational collaboration. Learners who are part of the City Cancer Challenge's project can access additional education provided by them.

Please login or register. Then you can use this button to confirm you are part of this project.
Register for free Already have an account? Login
Videos [917]
News [2627]
Articles [115]
Editorials [3]
Conferences [85]
elearning [27]
Almost two thousand UK lung cancer patients missing out on surgery every year
Almost two thousand UK lung cancer patients missing out on surgery every year
Oncologist participation in tumour board meetings may be associated with improved outcomes for patients with lung or colorectal cancers
Oncologist participation in tumour board meetings may be associated with improved outcomes for patients with lung...
Researchers reveal lung cancer can stay hidden for over 20 years
Researchers reveal lung cancer can stay hidden for over 20 years
The Ninth International Conference of Anticancer Research: Part two: HOX Genes and Cancer
The Ninth International Conference of Anticancer Research: Part two: HOX Genes and Cancer
ESMO 2014: Dabrafenib anti-tumour activity in BRAF V600E mutation-positive non-small cell lung cancer
ESMO 2014: Dabrafenib anti-tumour activity in BRAF V600E mutation-positive non-small cell lung cancer
ESMO 2014: HER2 inhibition shows promise in HER2-positive non-small cell lung cancer
ESMO 2014: HER2 inhibition shows promise in HER2-positive non-small cell lung cancer
ESMO 2014: PD-L1 protein a possible immunotherapy target in mesothelioma
ESMO 2014: PD-L1 protein a possible immunotherapy target in mesothelioma
ESMO 2014: High-dose radiotherapy adds no survival benefit after chemotherapy and radical surgery in mesothelioma
ESMO 2014: High-dose radiotherapy adds no survival benefit after chemotherapy and radical surgery in mesothelioma
ESMO 2014: Phase III trial results raise questions about the future of lung cancer vaccination
ESMO 2014: Phase III trial results raise questions about the future of lung cancer vaccination
ESMO 2014: Little benefit for gefitinib-resistant lung cancer when continuing the drug with chemo
ESMO 2014: Little benefit for gefitinib-resistant lung cancer when continuing the drug with chemo
<1...195196197198199...263>

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation

  • Contact
  • Projects
  • Cookie Policy
  • Terms of Use
  • Desktop Site
  • Privacy Policy
© 2025 ecancer, all rights reserved
UK registered charity number: 1176307
Back to Top